248 related articles for article (PubMed ID: 20645080)
1. Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats.
Rodsiri R; Spicer C; Green AR; Marsden CA; Fone KC
Psychopharmacology (Berl); 2011 Feb; 213(2-3):365-76. PubMed ID: 20645080
[TBL] [Abstract][Full Text] [Related]
2. Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats.
Piper BJ; Ali SF; Daniels LG; Meyer JS
Synapse; 2010 Jun; 64(6):421-31. PubMed ID: 20169574
[TBL] [Abstract][Full Text] [Related]
3. Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA.
Green AR; Sanchez V; O'Shea E; Saadat KS; Elliott JM; Colado MI
Psychopharmacology (Berl); 2004 May; 173(3-4):264-9. PubMed ID: 14726996
[TBL] [Abstract][Full Text] [Related]
4. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
5. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
6. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain.
Izco M; Orio L; O'Shea E; Colado MI
Psychopharmacology (Berl); 2007 Jan; 189(4):459-70. PubMed ID: 17047928
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.
Baumann MH; Clark RD; Franken FH; Rutter JJ; Rothman RB
Neuroscience; 2008 Mar; 152(3):773-84. PubMed ID: 18313226
[TBL] [Abstract][Full Text] [Related]
8. The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature.
Saadat KS; O'shea E; Colado MI; Elliott JM; Green AR
Psychopharmacology (Berl); 2005 Jun; 179(4):884-90. PubMed ID: 15650843
[TBL] [Abstract][Full Text] [Related]
9. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose.
Esteban B; O'Shea E; Camarero J; Sanchez V; Green AR; Colado MI
Psychopharmacology (Berl); 2001 Mar; 154(3):251-60. PubMed ID: 11351932
[TBL] [Abstract][Full Text] [Related]
10. 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion.
Orio L; O'Shea E; Sanchez V; Pradillo JM; Escobedo I; Camarero J; Moro MA; Green AR; Colado MI
J Neurochem; 2004 Jun; 89(6):1445-53. PubMed ID: 15189347
[TBL] [Abstract][Full Text] [Related]
11. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.
O'Loinsigh ED; Boland G; Kelly JP; O'Boyle KM
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):621-38. PubMed ID: 11371001
[TBL] [Abstract][Full Text] [Related]
12. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
Colado MI; Williams JL; Green AR
Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
[TBL] [Abstract][Full Text] [Related]
13. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
O'Shea E; Escobedo I; Orio L; Sanchez V; Navarro M; Green AR; Colado MI
Neuropsychopharmacology; 2005 Jul; 30(7):1312-23. PubMed ID: 15688085
[TBL] [Abstract][Full Text] [Related]
14. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR
Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492
[TBL] [Abstract][Full Text] [Related]
15. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.
Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS
Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
Goñi-Allo B; Puerta E; Hervias I; Di Palma R; Ramos M; Lasheras B; Aguirre N
Eur J Pharmacol; 2007 May; 562(3):198-207. PubMed ID: 17320075
[TBL] [Abstract][Full Text] [Related]
17. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine.
Colado MI; O'Shea E; Granados R; Murray TK; Green AR
Br J Pharmacol; 1997 Jul; 121(5):889-900. PubMed ID: 9222545
[TBL] [Abstract][Full Text] [Related]
18. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
Freezer A; Salem A; Irvine RJ
Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
[TBL] [Abstract][Full Text] [Related]
19. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.
Shankaran M; Gudelsky GA
Psychopharmacology (Berl); 1999 Nov; 147(1):66-72. PubMed ID: 10591870
[TBL] [Abstract][Full Text] [Related]
20. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats.
Gramsbergen JB; Cumming P
Neurochem Int; 2007 Jul; 51(1):8-15. PubMed ID: 17475367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]